and Beaza, when I say that all may make sense in time, I really mean that. Things can easily turn given the outcomes available to us and the end game on offer….. what I’m stating is the date, the lack of formal updates to market and the conundrum facing shareholders left…… in the lurch. Don’t make me start quoting Dr Zeus
FDA delay for ph 3 trial approval, page-73
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.010(4.76%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.0¢ | $221.1K | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 324368 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10349 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |